Johnson & Johnson ends partnership with Bavarian Nordic on hepatitis B and HPV vaccines
- Normal Liver Cells Found to Promote Cancer Metastasis to the Liver
- Nearly 80% Complete Remission: Breakthrough in ADC Anti-Tumor Treatment
- Vaccination Against Common Diseases May Prevent Dementia!
- New Alzheimer’s Disease (AD) Diagnosis and Staging Criteria
- Breakthrough in Alzheimer’s Disease: New Nasal Spray Halts Cognitive Decline by Targeting Toxic Protein
- Can the Tap Water at the Paris Olympics be Drunk Directly?
Johnson & Johnson ends partnership with Bavarian Nordic on hepatitis B and HPV vaccines
- Should China be held legally responsible for the US’s $18 trillion COVID losses?
- CT Radiation Exposure Linked to Blood Cancer in Children and Adolescents
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
Johnson & Johnson ends partnership with Bavarian Nordic on hepatitis B and HPV vaccines
On May 9, Johnson & Johnson announced that it had terminated its partnership and licensing agreement with Bavarian Nordic.
The main content of the agreement is to use Bavarian Nordic’s MVA-BN technology to develop potential vaccines against hepatitis B virus and human papilloma virus. Currently, J&J has not used the technology to develop a hepatitis B vaccine.
For hepatitis B, Johnson & Johnson will continue to prioritize the use of its technology platform to develop related therapeutic drugs. Because hepatitis B remains a serious health problem, about 296 million people worldwide are affected by the disease, and nearly 900,000 people die from it every year.
For human papillomavirus, J&J does not intend to focus its research on its therapeutic vaccine because a preventive vaccine is already widely used.
However, J&J’s collaboration with the company on HIV and Ebola is still ongoing.
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.